741286-41-9

Basic information

• Product Name: Ethyl 3-Methyl-a,g-dioxo-benzenebutanoate
• Synonyms: Ethyl 3-Methyl-a,g-dioxo-benzenebutanoate
• CAS NO: 741286-41-9
• Molecular Weight: 234.252
• Mol File: 741286-41-9.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: Ethyl 3-Methyl-a,g-dioxo-benzenebutanoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 3-Methyl-a,g-dioxo-benzenebutanoate(741286-41-9)
• EPA Substance Registry System: Ethyl 3-Methyl-a,g-dioxo-benzenebutanoate(741286-41-9)

Safety Data

• Hazardous Substances Data: 741286-41-9(Hazardous Substances Data)

Upstream product

• 7287-81-2 1-(m-methylphenyl)ethanol 
• 620-23-5 m-tolyl aldehyde 
• 95-92-1 oxalic acid diethyl ester 
• 585-74-0 3-Methylacetophenone 

Downstream Products

• 1316754-28-5 ethyl 3-(m-tolyl)-1H-pyrazole-5-carboxylate 
• 887979-11-5 5-(3-methylphenyl)isoxazole-3-carboxylic acid 
• 1378938-20-5 2-amino-3-cyano-7-dimethylamino-4-(5-(3-methylphenyl)-isoxazol-3-yl)-4H-chromene 
• 1018680-79-9 5-m-tolyl-isoxazole-3-carbaldehyde 
• 893638-95-4 [5-(3-Methyl-phenyl)-isoxazol-3-yl]-methanol 
• 893638-47-6 ethyl 5-(3-methylphenyl)isoxazole-3-carboxylate 
• 1316754-43-4 C₂₄H₂₉N₅O 
• 1316754-37-6 C₁₁H₁₀N₂O₂ 
• 741291-47-4 1-(6-methoxy-3-pyridyl)-5-(3-methylphenyl)pyrazole-3-carboxylic acid ethyl ester 

Relevant articles and documents

PIKFYVE KINASE INHIBITORS

The present invention relates to compounds useful as inhibitors of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) as well as their use for treating diseases and disorders associated with PIKfyve.

Ruthenium-Catalyzed Asymmetric Transfer Hydrogenation of β-Substituted α-Oxobutyrolactones

A concise and effective ruthenium-catalyzed asymmetric transfer hydrogenation of β-substituted α-oxobutyrolactones has been developed, delivering a series of cis-β-substituted α-hydroxybutyrolactone derivatives with excellent yields, enantioselectivities,

Green and efficient synthesis of new pyrido[2,3-d]pyrimidine derivatives using Pd/SBA-15 as a nanocatalyst

N-Fused heterocycles have received significant attention over the years as valuable compounds due to their biological and pharmaceutical activities. Heterogeneous catalysts such as periodic mesoporous materials have played an important role in the synthes